Spes Immunotherapeutics

Private

Sant Cugat del VallèsHealthcare & Life Scienceshttp://spesimmuno.com/

Company Overview

Spes Immunotherapeutics is a biotechnology company that develops personalized therapeutic vaccines to prevent leukemia relapse in children.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

therapeutic vaccinepediatric leukemianeoantigen selectionprecision medicinecancer immunotherapylipid nanoparticleLNPAI-driven drug discoverypersonalized medicinebiotech spin-offclinical developmentinvestigational new drugINDcomputational biologycancer vaccine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spes Immunotherapeutics Comparables

Compare Spes Immunotherapeutics with similar companies based on industry and business-model similarity.

Spes Immunotherapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Kindling Bio	75%
BioNTech SE	70%
Evaxion A/S	68%

View all Comparables

Spes Immunotherapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Spes Immunotherapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Spes Immunotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spes Immunotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSant Cugat del Vallès

Year Founded2024

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?